Preview

Clinical Medicine (Russian Journal)

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Potential of stem cells in tissue and organ regeneration, current clinical trials

https://doi.org/10.30629/0023-2149-2025-103-2-85-91

Abstract

Regenerative medicine, based on the use of stem cells (SC), represents one of the most promising areas of modern medicine. Objective: to explore the possibilities of using SC in the restoration of tissues and organs, as well as to analyze current clinical trials in this field. Material and methods. The article examines types of SC such as embryonic, pluripotent, and mesenchymal stem cells, and analyzes current clinical trials regarding their application. Results. The main focus is on the mechanisms of action of SC after transplantation, issues of their long-term safety, mechanisms of differentiation, and integration into the tissues of the body. Conclusion. Despite the progress made, the application of SC is associated with a number of unresolved issues, such as the risk of malignant transformation of cells and the possibility of virus transmission during allogeneic transplantation.

About the Authors

A. A. Semakov
North-Western State Medical University named after I.I. Mechnikov of the Ministry of Health of Russia
Russian Federation

St. Petersburg



E. G. Sapego
Altai State Medical University of the Ministry of Health of Russia
Russian Federation

Barnaul



E. D. Kirienkova
Russian University of Medicine of the Ministry of Health of Russia
Russian Federation

Moscow



V. D. Soldatova
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia (Sechenov University)
Russian Federation

Moscow



K. I. Sfieva
N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia
Russian Federation

Moscow



References

1. Cossu G., Birchall M., Brown T., De Coppi P., Culme-Seymour E., Gibbon S. et al. Lancet Commission: Stem cells and regenerative medicine. Lancet. 2018;391(10123):883–910. DOI: 10.1016/S0140-6736(17)31366-1

2. Bacakova L., Zarubova J., Travnickova M., Musilkova J., Pajorova J., Slepicka P. et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells – a review. Biotechnol Adv. 2018;36(4):1111–1126. DOI: 10.1016/j.biotechadv.2018.03.011

3. Si Z., Wang X., Sun C., Kang Y., Xu J., Wang X., Hui Y. Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies. Biomed Pharmacother. 2019;114:108765. DOI: 10.1016/j.biopha.2019.108765

4. Suman S., Domingues A., Ratajczak J., Ratajczak M.Z. Potential Clinical Applications of Stem Cells in Regenerative Medicine. Adv. Exp. Med. Biol. 2019;1201:1–22. DOI: 10.1007/978-3-030-31206-0_1

5. Sarkar A., Saha S., Paul A., Maji A., Roy P., Maity T.K. Understanding stem cells and its pivotal role in regenerative medicine. Life Sci. 2021;273:119270. DOI: 10.1016/j.lfs.2021.119270

6. Huang Y.Z., He T., Cui J., Jiang Y.L., Zeng J.F., Zhang W.Q., Xie H.Q. Urine-derived stem cells for regenerative medicine: basic biology, applications, and challenges. Tissue Eng. Part B Rev. 2022;28(5):978–994. DOI: 10.1089/ten.teb.2021.0142

7. Bento G., Shafi gullina A.K., Rizvanov A.A., Sardão V.A., Macedo M.P., Oliveira P.J. Urine-derived stem cells: applications in regenerative and predictive medicine. Cells. 2020;9(3):573. DOI: 10.3390/cells9030573

8. Qin Y., Ge G., Yang P., Wang L., Qiao Y., Pan G. et al. An Update on adipose-derived stem cells for regenerative medicine: where challenge meets opportunity. Adv. Sci. (Weinh). 2023;10(20):e2207334. DOI: 10.1002/advs.202207334

9. Doğan A. Embryonic stem cells in development and regenerative medicine. Adv. Exp. Med. Biol. 2018;1079:1–15. DOI: 10.1007/5584_2018_175

10. Irgasheva D.Z., Abdullozoda S.M., Shukurov F.A., Khalimova F.T. The use of stem cells in medicine (historical aspect)]. Biology and Integrative Medicine. 2023;6(65):43–67. (In Russian). DOI: 10.24412/cl-34438-2023-665-43-68

11. Karpenko D.V., Bigildeev A.E. Mutual regulation of stem and immune cells in tissue-specific stem niches. Genes and cells. 2022;7(3)]. (In Russian).

12. Madina Z.I. Cell differentiation, stimulation of proliferation and hematopoietic stem cells prethymocytes, thymocytes. Science and Education. 2024;5(3):69–76. (In Russian).

13. Khalimova F.T., Shumilina O.V., Safarzoda A.M. Modulation of immune system activity by stem cells (literature review)]. Biology and Integrative Medicine. 2023;4(63):108–124. (In Russian).

14. Mikhalevich S.I., Buryak D.V., Kreer S.A., Poleshko A.G., Vladimirskaya T.E., Ustemchuk A.M., Volotovsky I.D. Morphological changes in the tissues of the uterus of laboratory animals under the influence of mesenchymal stem cells. Medical news. 2021;6(321):77–80. (In Russian).

15. Kondrashov V.A., Shchapkova M.M., Pugacheva M.G. Features of stem cell aging. Bulletin of Science. 2020;9(30):50–52. (In Russian).

16. Keshtkar S., Azarpira N., Ghahremani M.H. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem. Cell Res. Ther. 2018;9(1):63. DOI: 10.1186/s13287-018-0791-7

17. Tatullo M., Piattelli A., Zavan B. Regenerative Medicine: Role of Stem Cells and Innovative Biomaterials 2.0. Int. J. Mol. Sci. 2022;23(8):4199. DOI: 10.3390/ijms23084199

18. Wang J., Chen Z., Sun M., Xu H., Gao Y., Liu J., Li M. Characterization and therapeutic applications of mesenchymal stem cells for regenerative medicine. Tissue Cell. 2020;64:101330. DOI: 10.1016/j.tice.2020.101330

19. Papa S., Pizzetti F., Perale G., Veglianese P., Rossi F. Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials. Expert Opin. Biol. Ther. 2020;20(10):1203–1213. DOI: 10.1080/14712598.2020.1770725

20. Dupont G., Yilmaz E., Loukas M., Macchi V., De Caro R., Tubbs R.S. Human embryonic stem cells: Distinct molecular personalities and applications in regenerative medicine. Clin. Anat. 2019;32(3):354–360. DOI: 10.1002/ca.23318

21. Kim S., Chang K.A., Kim Ja., Park H.G., Ra J.C., Kim H.S., Suh Y.H. The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer’s disease mice. PLoS One. 2012;7(9):e45757. DOI: 10.1371/journal.pone.0045757

22. Marconi S., Bonaconsa M., Scambi I., Squintani G.M., Rui W., Turano E. et al. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience. 2013;248:333–43. DOI: 10.1016/j.neuroscience.2013.05.034

23. Zhou Y., Sun M., Li H., Yan M., He Z., Wang W., Wang W., Lu S. Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy. Cytotherapy. 2013;15(4):467–80. DOI: 10.1016/j.jcyt.2013.01.007.

24. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105(1):93–8. DOI: 10.1161/hc0102.101442

25. Quevedo H.C., Hatzistergos K.E., Oskouei B.N., Feigenbaum G.S., Rodriguez J.E., Valdes D. et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci USA. 2009;106(33):14022–7. DOI: 10.1073/pnas.0903201106

26. Dokshin P.M., Malashicheva A.B. Heart stem cells: hope or myth? Russian Journal of Cardiology. 2021;26(10):4749. (In Russian). DOI: 10.15829/1560-4071-2021-4749

27. Strauer B.E., Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J. Am. Coll. Cardiol. 2011;58(11):1095–104. DOI: 10.1016/j.jacc.2011.06.016

28. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J. et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94(1):92–5. DOI: 10.1016/j.amjcard.2004.03.034

29. Williams A.R., Trachtenberg B., Velazquez D.L., McNiece I., Altman P., Rouy D. et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ. Res. 2011;108(7):792–6. DOI: 10.1161/CIRCRESAHA.111.242610

30. Lykov A.P. Mesenchymal stem cells: properties and clinical applications. Siberian scientific medical journal. 2023;43(2):40–53. (In Russian).

31. Mozheiko L.A. Obtaining insulin-producing cells from embryonic and induced pluripotent stem cells. Journal of Grodno State Medical University. 2021;19(4):376–381. (In Russian). DOI: 10.25298/2221-8785-2021-19-4-376-382

32. Mi L., Hu J., Li N., Gao J., Huo R., Peng X. et al. The mechanism of stem cell aging. Stem. Cell. Rev. Rep. 2022;18(4):1281–1293. DOI: 10.1007/s12015-021-10317-5

33. Ganiev O.A., Valiev EYu., Karimov B.R., Azizov S.H. Modern possibilities of using mesenchymal stem cells in traumatology and orthopedics. Bulletin of emergency medicine. 2022;15(6):73–80. (In Russian). DOI: 10.54185/TBEM/vol15_iss6/a14

34. Alekseev A.A., Filimonov K.A., Panteleev A.A., Bobrovnikov A.A. Modern biotechnological methods in the complex treatment of thermal injuries. Genes and cells. 2022:7(3)]. (In Russian).


Review

For citations:


Semakov A.A., Sapego E.G., Kirienkova E.D., Soldatova V.D., Sfieva K.I. Potential of stem cells in tissue and organ regeneration, current clinical trials. Clinical Medicine (Russian Journal). 2025;103(2):85-91. (In Russ.) https://doi.org/10.30629/0023-2149-2025-103-2-85-91

Views: 156


ISSN 0023-2149 (Print)
ISSN 2412-1339 (Online)